According to Spero Therapeutics's latest financial reports the company's current revenue (TTM ) is $34.08 Million USD. In 2024 the company made a revenue of $27.39 Million USD a decrease over the revenue in the year 2023 that were of $96.73 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.